{"id":"https://openalex.org/W2058738521","doi":"https://doi.org/10.1097/yic.0b013e3282f2b3cb","title":"The under-recognized role of dopamine in the treatment of major depressive disorder","display_name":"The under-recognized role of dopamine in the treatment of major depressive disorder","alternate_titles":[],"publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W2058738521","doi":"https://doi.org/10.1097/yic.0b013e3282f2b3cb","mag":"2058738521","pmid":"https://pubmed.ncbi.nlm.nih.gov/18301120"},"language":"en","primary_location":{"id":"doi:10.1097/yic.0b013e3282f2b3cb","doi":"https://doi.org/10.1097/yic.0b013e3282f2b3cb","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yic.0b013e3282f2b3cb","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2058738521"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002162783","display_name":"Stuart Montgomery","orcid":"https://orcid.org/0000-0002-5983-0063","observed_orcids":["https://orcid.org/0000-0002-5983-0063"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Stuart A. Montgomery","raw_affiliation_strings":["Imperial College School of Medicine, London, UK. stuart@samontgomery.co.uk","Imperial College School of Medicine, London, UK","to Professor Stuart A. Montgomery, Imperial College School of Medicine, PO Box 8751, London W13 8WH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College School of Medicine, London, UK. stuart@samontgomery.co.uk","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Imperial College School of Medicine, London, UK","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"to Professor Stuart A. Montgomery, Imperial College School of Medicine, PO Box 8751, London W13 8WH, UK","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002162783"],"corresponding_institution_ids":["https://openalex.org/I47508984"],"apc_list":null,"apc_paid":null,"fwci":0.5227,"has_fulltext":false,"cited_by_count":38,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.42147117,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"23","issue":"2","first_page":"63","last_page":"69"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":1.0},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9729999899864197},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9850000143051147},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/bipolar-depression","display_name":"bipolar depression","score":0.746999979019165},{"id":"https://openalex.org/keywords/antidepressant-treatment","display_name":"antidepressant treatment","score":0.5809999704360962},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/serotonin-norepinephrine-reuptake-inhibitors","display_name":"serotonin-norepinephrine reuptake inhibitors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/neurotransmitter-deficiency","display_name":"neurotransmitter deficiency","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.813987135887146},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.7887762784957886},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.6294766068458557},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.6174371242523193},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5993750095367432},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5079792141914368},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.4937170445919037},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4625266194343567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4582196772098541},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.45117491483688354},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.44892120361328125},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4225379228591919},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.34225502610206604},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2632901668548584},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25839030742645264},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.1289217472076416},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.09351891279220581},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/yic.0b013e3282f2b3cb","doi":"https://doi.org/10.1097/yic.0b013e3282f2b3cb","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yic.0b013e3282f2b3cb","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:18301120","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18301120","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W84424268","https://openalex.org/W108869947","https://openalex.org/W141608893","https://openalex.org/W1569413811","https://openalex.org/W1579155080","https://openalex.org/W1867335213","https://openalex.org/W1968455975","https://openalex.org/W1982303831","https://openalex.org/W1982472872","https://openalex.org/W1984646527","https://openalex.org/W1987671737","https://openalex.org/W1988849721","https://openalex.org/W1991887171","https://openalex.org/W1992490627","https://openalex.org/W1995358122","https://openalex.org/W1996105921","https://openalex.org/W2003868665","https://openalex.org/W2005066505","https://openalex.org/W2020739757","https://openalex.org/W2029109091","https://openalex.org/W2034750014","https://openalex.org/W2037486662","https://openalex.org/W2043046773","https://openalex.org/W2045422537","https://openalex.org/W2046293215","https://openalex.org/W2049548914","https://openalex.org/W2052126530","https://openalex.org/W2053782164","https://openalex.org/W2054594132","https://openalex.org/W2056513437","https://openalex.org/W2059515744","https://openalex.org/W2060456881","https://openalex.org/W2064002445","https://openalex.org/W2068927187","https://openalex.org/W2069090735","https://openalex.org/W2069778584","https://openalex.org/W2073653054","https://openalex.org/W2075911308","https://openalex.org/W2079314303","https://openalex.org/W2085525314","https://openalex.org/W2089496191","https://openalex.org/W2092430566","https://openalex.org/W2094034945","https://openalex.org/W2095109387","https://openalex.org/W2095141617","https://openalex.org/W2097648013","https://openalex.org/W2099564543","https://openalex.org/W2101372256","https://openalex.org/W2111355579","https://openalex.org/W2122016047","https://openalex.org/W2124216937","https://openalex.org/W2125094332","https://openalex.org/W2128853507","https://openalex.org/W2137296158","https://openalex.org/W2149926924","https://openalex.org/W2151852296","https://openalex.org/W2152769424","https://openalex.org/W2153381163","https://openalex.org/W2159061031","https://openalex.org/W2168915747","https://openalex.org/W2367662090","https://openalex.org/W2464692596","https://openalex.org/W3164656276","https://openalex.org/W4244103373","https://openalex.org/W4399865119"],"related_works":["https://openalex.org/W2781702342","https://openalex.org/W2074874853","https://openalex.org/W1970677460","https://openalex.org/W1965831048","https://openalex.org/W2119211687","https://openalex.org/W7140775232","https://openalex.org/W4400415795","https://openalex.org/W2939760467","https://openalex.org/W2025753477","https://openalex.org/W2092091703"],"abstract_inverted_index":{"Major":[0],"depressive":[1],"disorder":[2],"(MDD)":[3],"is":[4,27,103],"currently":[5],"the":[6,35,39,72,99],"second":[7],"most":[8],"common":[9],"cause":[10],"of":[11,16,41,89,101],"disability":[12],"worldwide.":[13],"Current":[14],"treatment":[15,40,67,74,100],"MDD":[17,55,80,102],"with":[18,43,79,117],"selective":[19],"serotonin":[20,48],"reuptake":[21,25],"inhibitors":[22,26],"and":[23,31,49,81,96,112],"serotonin-noradrenaline":[24],"limited":[28],"by":[29],"efficacy":[30],"tolerability":[32],"issues,":[33],"highlighting":[34],"unmet":[36],"need":[37],"in":[38,46,98,115],"patients":[42,78,116],"MDD.":[44,118],"Deficiencies":[45],"dopamine,":[47],"noradrenaline":[50],"are":[51],"thought":[52],"to":[53],"underpin":[54],"pathophysiology.":[56],"Atypical":[57],"antipsychotics,":[58],"which":[59],"modulate":[60],"these":[61],"receptor":[62],"systems,":[63],"may":[64],"provide":[65],"additional":[66],"options.":[68],"This":[69],"article":[70],"assesses":[71],"current":[73],"options":[75],"available":[76],"for":[77],"considers":[82],"possible":[83],"future":[84],"therapies.":[85],"The":[86],"potential":[87],"role":[88],"atypical":[90],"antipsychotics":[91],"such":[92],"as":[93],"olanzapine,":[94],"risperidone":[95],"quetiapine":[97],"explored":[104],"based":[105],"on":[106],"evidence":[107],"from":[108],"bipolar":[109],"depression":[110],"trials":[111],"preliminary":[113],"studies":[114]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2058738521","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
